Azilect
Azilect Price range: $ 17,00 through $ 46,00
Back to products
Azithromycin DT
Azithromycin DT Price range: $ 60,00 through $ 972,00

Azipro

Price range: $ 90,00 through $ 680,00

Azipro is a potent macrolide antibiotic formulated to combat a variety of bacterial infections throughout the body. The active ingredient works by inhibiting the growth of bacteria, allowing the immune system to effectively clear the infection. It is widely utilized for treating respiratory conditions, including community-acquired pneumonia, bronchitis, and throat infections. Additionally, this medication provides reliable relief for skin structure infections and acute middle ear infections. Its long half-life ensures that the treatment remains effective even with a short and convenient dosing course.

Active substance: Azithromycin
SKU: Azipro Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Azipro belongs to a group of medicines called macrolide antibacterials and contains the active substance azithromycin. It is an oral prescription medication indicated for the treatment of specific mild-to-moderate bacterial infections in adult and pediatric patients under appropriate clinical supervision.

As a prescription-only pharmaceutical regulated by the U.S. Food and Drug Administration (FDA), Azipro must be dispensed in accordance with federal and state regulations. Proper administration under medical guidance ensures optimal therapeutic outcomes while minimizing the risk of developing antimicrobial resistance.

Clinical Profile and Basic Information

Parameter Specification
Drug Name Azipro
Active Ingredient Azithromycin
Therapeutic Class Macrolide antibacterial
Route of Administration Oral
Prescription Status Prescription (Rx) required
Primary Purpose Treatment of susceptible bacterial infections

Main Uses

Azipro is FDA-approved for the treatment of acute bacterial infections caused by susceptible strains of designated microorganisms. Primary clinical indications include acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD), community-acquired pneumonia of mild severity, acute bacterial sinusitis, and streptococcal pharyngitis or tonsillitis as an alternative therapy. It is also indicated for uncomplicated skin and skin structure infections, as well as non-gonococcal urethritis and cervicitis caused by Chlamydia trachomatis.

Off-label indications–such as long-term maintenance therapy in non-cystic fibrosis bronchiectasis or specific prophylaxis protocols for traveler’s diarrhea–must be explicitly evaluated, initiated, and monitored by a qualified healthcare professional, as dosing strategies and risk profiles differ significantly from standard antibacterial regimens.

Mechanism of Action

Azipro exerts its antibacterial effect by reversibly binding to the 50S ribosomal subunit of susceptible microorganisms. This action blocks transpeptidation and translocation steps during protein synthesis, thereby inhibiting nascent peptide chain elongation and halting microbial cellular growth. Because it targets bacterial ribosome architecture, human protein synthesis remains unaffected at therapeutic drug levels.

Azithromycin is predominantly bacteriostatic; however, it can exhibit bactericidal activity against select bacterial strains at higher concentrations. The drug demonstrates extensive distribution into human tissues, resulting in intracellular concentrations in leukocytes and fibroblasts that significantly exceed plasma concentrations. During active immune responses, circulating phagocytes transport the active drug directly to the site of infection.

How It Is Absorbed and Eliminated

Following oral administration, azithromycin is rapidly absorbed from the gastrointestinal tract, achieving peak plasma concentrations within 2 to 3 hours. Administration with food does not significantly alter overall systemic bioavailability of oral tablets, though it may alter peak plasma levels depending on formulation.

The elimination profile is characterized by extensive tissue distribution and a prolonged terminal elimination half-life of approximately 68 hours. Biliary excretion represents the primary pathway for drug elimination, with unchanged active drug excreted into the bile. A minor fraction of the administered dose (approximately 12%) is excreted unchanged in urine over a multi-day period. Consequently, plasma clearance remains low while tissue retention remains high over several days post-treatment.

Dosing, Precautions, and Safety Profile

Dosing Schedule

Dosing of Azipro must be individually determined by a licensed prescriber based on the specific clinical indication, patient age, body weight, and renal functionality. For standard mild-to-moderate respiratory tract and skin infections in adults, a common therapeutic regimen consists of an initial 500 mg single dose on Day 1, followed by 250 mg once daily on Days 2 through 5, delivering a cumulative dose of 1.5 grams.

For single-dose treatment regimens, such as non-gonococcal urethritis caused by Chlamydia trachomatis, a single 1000 mg (1 gram) oral dose is administered. Patients must swallow tablets whole with adequate fluid. Completing the entire course of therapy as prescribed is critical, even if clinical symptoms dissipate early, to prevent microbial recrudescence and the selection of resistant bacterial isolates.

Compatibility With Other Medicines

Co-administration of Azipro with aluminum- or magnesium-containing antacids reduces peak serum concentrations of azithromycin; therefore, simultaneous intake should be avoided, maintaining an administration interval of at least two hours. Caution is advised when prescribing azithromycin alongside medications known to prolong the QT interval, such as antiarrhythmic agents (e.g., amiodarone, sotalol, quinidine) and certain antipsychotic or antidepressant agents.

Concomitant administration with oral anticoagulants, including warfarin, may augment prothrombin time; routine monitoring of international normalized ratio (INR) values is recommended. Azithromycin may also elevate serum concentrations of cardiac glycosides like digoxin via altered intestinal clearance pathways, requiring vigilance for clinical signs of digoxin toxicity.

Adverse Reactions

The adverse reaction profile of Azipro is predominantly gastrointestinal in nature. Clinical trials demonstrate that the most frequently reported side effects include mild-to-moderate nausea, diarrhea or loose stools, abdominal pain, vomiting, and flatulence. Nervous system events such as headache, dizziness, or temporary altered taste perceptions occur in a smaller subset of patients.

Less common but serious adverse events demand immediate medical surveillance. These include severe cutaneous hypersensitivity reactions (such as Stevens-Johnson syndrome or toxic epidermal necrolysis), acute hepatotoxicity manifested by elevated hepatic transaminases or cholestatic jaundice, Clostridioides difficile-associated diarrhea, and cardiac electrophysiological alterations including prolonged QT intervals and ventricular arrhythmias.

Important Precautions

Azipro is strictly contraindicated in patients with a history of severe allergic reactions to azithromycin, erythromycin, or any macrolide/ketolide derivative, as well as patients with a history of cholestatic jaundice or hepatic dysfunction associated with prior azithromycin therapy. Severe hepatotoxicity, including fatal hepatic necrosis, has been reported; treatment must cease immediately if clinical signs of hepatitis develop.

Precautions should be exercised in patients with baseline cardiac conditions, specifically those with uncorrected hypokalemia or hypomagnesemia, clinically significant bradycardia, or concurrent administration of QT-prolonging drugs. In pregnant or nursing women, use is indicated only when clearly needed after a professional risk-benefit evaluation.

What You May Notice Early On

Within the initial 24 to 48 hours following commencement of Azipro therapy, patients typically observe a stabilization of acute infection symptoms, such as reduced systemic fever or diminished localized pain. Mild gastrointestinal disturbances–including transient nausea or altered bowel habits–may occur early during treatment as the medication is absorbed.

Because azithromycin accumulates preferentially inside body tissues over several days, therapeutic efficacy continues even after short oral treatment courses are completed. Immediate elimination of all symptoms after a single dose should not be expected, but progressive clinical recovery should occur over the prescribed treatment window.

If You Skip a Dose

If a dose of Azipro is missed, it should be taken as soon as remembered on the same day. However, if the time is close to the next scheduled dose, the missed dose should be omitted, and the regular schedule resumed. Patients must not double the prescribed dose to compensate for a missed tablet, as high single doses increase the risk of acute gastrointestinal distress and systemic toxicity.

What to Avoid While Taking It

Azipro tablets may be taken with or without food; taking a dose alongside a meal can help reduce light stomach discomfort. Avoid co-administering aluminum- or magnesium-based antacids within two hours of taking azithromycin, as inorganic salts impair systemic absorption rates.

While alcohol does not directly neutralize the antibacterial mechanism of azithromycin, alcohol consumption during active systemic infection can worsen gastrointestinal side effects, cause dehydration, and impair overall host immune function. Limiting or avoiding alcohol during the course of antibacterial therapy is clinically recommended.

Storage and Expiration

Store Azipro tablets at controlled room temperature between 20°C to 25°C (68°F to 77°F), with permitted excursions between 15°C and 30°C (59°F to 86°F). Keep the container tightly sealed to protect the medication from excessive moisture, heat, and direct light exposure. Do not store in high-humidity areas like bathroom cabinets.

Keep all prescription drugs safely out of the reach of children and domestic animals. Expired or unneeded medications should be disposed of properly through pharmacy take-back programs or in accordance with FDA guidelines for safe drug disposal, rather than flushed down household drains.

Common Questions

Q: Does Azipro affect the ability to drive or operate machinery?

A: Azipro generally does not impair cognitive or motor skills. However, side effects such as dizziness or fatigue may occur in some individuals. Patients should observe their personal response to the drug before driving or operating heavy equipment.

Q: What action should be taken if severe, watery diarrhea occurs during or after treatment?

A: Severe, persistent, or watery diarrhea–even occurring weeks after completing therapy–may signal Clostridioides difficile infection. Patients should contact their healthcare provider promptly and avoid taking anti-diarrheal medications like loperamide without medical advice.

Q: Can Azipro be discontinued early if fever and infection symptoms vanish completely?

A: No. Stopping an antibacterial regimen prematurely allows surviving bacteria to multiply, potentially causing infection relapse and promoting the development of drug-resistant strains. The full prescribed duration must be completed unless advised otherwise by a physician.

Q: How does Azipro interact with hormonal oral contraceptives?

A: Most macrolide antibiotics, including azithromycin, do not directly reduce the systemic efficacy of hormonal contraceptives. However, if Azipro causes severe vomiting or diarrhea, contraceptive absorption may be compromised, warranting temporary barrier protection.

Q: Are dosage adjustments necessary for patients with impaired renal function?

A: No dose adjustment is typically required for patients with mild-to-moderate renal impairment (GFR 10–80 mL/min). Caution and monitoring are advised in patients with severe renal impairment (GFR less than 10 mL/min) due to altered systemic exposure profiles.

This text is for informational purposes only and does not constitute individual medical advice.

In accordance with FDA requirements.

Additional information
Dosage

250mg

,

500mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία